OR06-05 Incidence and Risk Factors for Adrenal Crisis in Pediatric-onset Adrenal Insufficiency: A Multicenter, Prospective, Observational Study

Abstract T. Ishii: None. M. Hosokawa: None. Y. Ichihashi: None. Y. Sato: None. N. Shibata: None. K. Nagasaki: None. K. Ikegawa: None. Y. Hasegawa: None. T. Hamajima: None. F. Nagamatsu: None. S. Suzuki: None. C. Numakura: None. N. Amano: None. G. Sasaki: None. K. Nagahara: None. S. Soneda: None. D. Ariyasu: None. M. Maeda: None. H. Kamasaki: None. K. Aso: None. T. Hasegawa: None. Introduction: Adrenal crisis is a well-known life-threatening complication that occurs during follow-up of patients with adrenal insufficiency. No prospective study has thoroughly investigated adrenal crisis in children and adults with pediatric-onset primary or secondary adrenal insufficiency. Purpose: To determine the incidence and risk factors for adrenal crisis in patients with pediatric-onset adrenal insufficiency. Materials and methods: This multicenter, prospective cohort study enrolled patients diagnosed with adrenal insufficiency at ≤ 15 years of age. The incidence of adrenal crisis was calculated as events per person-year (PY), and risk factors for adrenal crisis were assessed using Poisson regression multivariable analysis. Results: The study population comprised 349 patients (164 male, 185 female) with a total follow-up of 961 PY. The median age at enrollment was 14.3 years (interquartile range [IQR] 8.5-21.2 years), and the median follow-up was 2.8 years (IQR 2.2-3.3 years). Of these patients, 213 (61%) had primary adrenal insufficiency and 136 (39%) had secondary adrenal insufficiency. Forty-one adrenal crisis events occurred in 31 patients during the study period. The calculated incidence of adrenal crisis was 4.27 per 100 PY (95% confidence interval [CI] of 3.15-5.75). Poisson regression analysis identified younger age at enrollment (relative risk [RR] 0.93 [95% CI 0.89-0.97]) and increased number of infections (RR 1.17 [95% CI 1.07-1.27]) as significant risk factors. Female sex (RR 0.99 [95% CI 0.53-1.86]), primary adrenal insufficiency (RR 0.65 [95 % CI 0.30-1.41]), or equivalent dosage of hydrocortisone per square meter of body area (RR 1.02 [95% CI 0.96-1.08]) was not a significant risk factor. Discussion and Conclusion: A substantial proportion of patients with pediatric-onset adrenal insufficiency experience adrenal crisis. Younger age and an increased number of infections are independent risk factors for developing adrenal crisis in these patients. Thus, particular attention should be devoted to younger patients and those who experience recurrent infections. Saturday, June 1, 2024

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2024-10-01
DOI
https://doi.org/10.1210/jendso/bvae163.2417
Primary Topic
Adrenal Hormones and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

OR06-05 Incidence and Risk Factors for Adrenal Crisis in Pediatric-onset Adrenal Insufficiency: A Multicenter, Prospective, Observational Study

Daisuke Ariyasu, Yasunori Sato, Keiko Aso, Chikahiko Numakura et al.
Journal of the Endocrine Society
Adrenal Hormones and Disorders
article

OR06-05 Incidence and Risk Factors for Adrenal Crisis in Pediatric-onset Adrenal Insufficiency: A Multicenter, Prospective, Observational Study

Daisuke Ariyasu, Yasunori Sato, Keiko Aso, Chikahiko Numakura, Miwako Maeda, Hotaka Kamasaki, Takashi Hamajima, Shun Soneda, Tomohiro Ishii, Mayumi Hosokawa, Naoko Amano, Fusa Nagamatsu, Yukihiro Hasegawa, Keisuke Nagasaki, Tomonobu Hasegawa, Shigeru Suzuki, Yosuke Ichihashi, Keiko Nagahara, Kento Ikegawa, Nao Shibata, Goro Sasaki
article en

Abstract

Abstract T. Ishii: None. M. Hosokawa: None. Y. Ichihashi: None. Y. Sato: None. N. Shibata: None. K. Nagasaki: None. K. Ikegawa: None. Y. Hasegawa: None. T. Hamajima: None. F. Nagamatsu: None. S. Suzuki: None. C. Numakura: None. N. Amano: None. G. Sasaki: None. K. Nagahara: None. S. Soneda: None. D. Ariyasu: None. M. Maeda: None. H. Kamasaki: None. K. Aso: None. T. Hasegawa: None. Introduction: Adrenal crisis is a well-known life-threatening complication that occurs during follow-up of patients with adrenal insufficiency. No prospective study has thoroughly investigated adrenal crisis in children and adults with pediatric-onset primary or secondary adrenal insufficiency. Purpose: To determine the incidence and risk factors for adrenal crisis in patients with pediatric-onset adrenal insufficiency. Materials and methods: This multicenter, prospective cohort study enrolled patients diagnosed with adrenal insufficiency at ≤ 15 years of age. The incidence of adrenal crisis was calculated as events per person-year (PY), and risk factors for adrenal crisis were assessed using Poisson regression multivariable analysis. Results: The study population comprised 349 patients (164 male, 185 female) with a total follow-up of 961 PY. The median age at enrollment was 14.3 years (interquartile range [IQR] 8.5-21.2 years), and the median follow-up was 2.8 years (IQR 2.2-3.3 years). Of these patients, 213 (61%) had primary adrenal insufficiency and 136 (39%) had secondary adrenal insufficiency. Forty-one adrenal crisis events occurred in 31 patients during the study period. The calculated incidence of adrenal crisis was 4.27 per 100 PY (95% confidence interval [CI] of 3.15-5.75). Poisson regression analysis identified younger age at enrollment (relative risk [RR] 0.93 [95% CI 0.89-0.97]) and increased number of infections (RR 1.17 [95% CI 1.07-1.27]) as significant risk factors. Female sex (RR 0.99 [95% CI 0.53-1.86]), primary adrenal insufficiency (RR 0.65 [95 % CI 0.30-1.41]), or equivalent dosage of hydrocortisone per square meter of body area (RR 1.02 [95% CI 0.96-1.08]) was not a significant risk factor. Discussion and Conclusion: A substantial proportion of patients with pediatric-onset adrenal insufficiency experience adrenal crisis. Younger age and an increased number of infections are independent risk factors for developing adrenal crisis in these patients. Thus, particular attention should be devoted to younger patients and those who experience recurrent infections. Saturday, June 1, 2024

Journal of the Endocrine SocietyVol. 8(Supplement_1)
Yamagata University (JP), SHOWA Medical University (JP), Asahikawa Medical College Hospital (JP), Toho University (JP), Sapporo Medical University (JP), St. Marianna University School of Medicine (JP), Oita University (JP), Keio University (JP), Toho University Omori Medical Center (JP), Tokyo Dental College Ichikawa General Hospital (JP), Children's Medical Center (IR), Kawasaki Municipal Hospital (JP), Niigata University Medical and Dental Hospital (JP), Saitama Municipal Hospital (JP), Tokyo Metropolitan Children's Medical Center (JP), Kumamoto University (JP)
Openalex Percentile: Top 60%
Adrenal Hormones and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.